ArticleNeuro-oncology advances

A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines.

Ashish H Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.